FREDA SMITH: Open Payments
NPI 1245758762 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,560 in 104 payments from 13 companies in 2025. Trend: 2023 $3,668 · 2024 $3,220 · 2025 $2,560
Food & beverage: $2,560
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $650 |
| UCB, Inc. | 15 | $322 |
| GENZYME CORPORATION | 9 | $301 |
| Janssen Biotech, Inc. | 9 | $269 |
| GlaxoSmithKline, LLC. | 7 | $244 |
| Amgen Inc. | 11 | $183 |
| AstraZeneca Pharmaceuticals LP | 9 | $180 |
| Lilly USA, LLC | 5 | $107 |
| Radius Health, Inc. | 5 | $102 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
Products named: RINVOQ, TREMFYA, Bimzelx, KEVZARA, BENLYSTA, SKYRIZI, SAPHNELO, EVENITY.
Industry payments across AL — which companies pay providers there.
